Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments.

MLA

Ngo, Carine, and Sophie Postel-Vinay. “Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments.” Biomedicines, vol. 10, no. 3, Mar. 2022. EBSCOhost, https://doi.org/10.3390/biomedicines10030650.

APA

Ngo, C., & Postel-Vinay, S. (2022). Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments. Biomedicines, 10(3). https://doi.org/10.3390/biomedicines10030650

Chicago

Ngo, Carine, and Sophie Postel-Vinay. 2022. “Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments.” Biomedicines 10 (3). doi:10.3390/biomedicines10030650.